The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic, AC Gonçalves… - Drug resistance …, 2019 - Elsevier
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

Cardio-oncology drug interactions: a scientific statement from the American Heart Association

CJ Beavers, JE Rodgers, AJ Bagnola, TM Beckie… - Circulation, 2022 - Am Heart Assoc
In the cardio-oncology population, drug interactions are of particular importance given the
complex pharmacological profile, narrow therapeutic index, and inherent risk of therapies …

Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF‐TIMI 48 trial

CL Fanola, CT Ruff, SA Murphy, J Jin… - Journal of the …, 2018 - Am Heart Assoc
Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging
because of enhanced risks for thrombosis and bleeding and the frequent need for invasive …

Sulfonamide inhibitors: a patent review 2013-present

İ Gulçin, P Taslimi - Expert opinion on therapeutic patents, 2018 - Taylor & Francis
Introduction: Sulfonamide compounds are significant class of synthetic bacteriostatic
antibiotics still which used today for the therapy of bacterial infections and those caused by …

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo

DA Sychev, GM Ashraf, AA Svistunov… - Drug design …, 2018 - Taylor & Francis
Cytochrome (CYP) 450 isoenzymes are the basic enzymes involved in Phase I
biotransformation. The most important role in biotransformation belongs to CYP3A4 …

Photosensitive Ru (II) complexes as inhibitors of the major human drug metabolizing enzyme CYP3A4

N Toupin, SJ Steinke, S Nadella, A Li… - Journal of the …, 2021 - ACS Publications
We report the synthesis and photochemical and biological characterization of the first
selective and potent metal-based inhibitors of cytochrome P450 3A4 (CYP3A4), the major …

Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system

HM Babiker, A McBride, M Newton, LM Boehmer… - Critical reviews in …, 2018 - Elsevier
Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

S Fogli, C Porta, M Del Re, S Crucitta… - Cancer Treatment …, 2020 - Elsevier
Anti-angiogenic treatment is an important option that has changed the therapeutic
landscape in various tumors, particularly in patients affected by renal cell carcinoma (RCC) …

[PDF][PDF] Integrating the epigenome to identify drivers of hepatocellular carcinoma

RA Hlady, A Sathyanarayan, JJ Thompson… - …, 2019 - Wiley Online Library
Disruption of epigenetic mechanisms has been intimately linked to the etiology of human
cancer. Understanding how these epigenetic mechanisms (including DNA methylation …

[HTML][HTML] Pharmacokinetic drug interactions in liver disease: an update

P Palatini, S De Martin - World Journal of Gastroenterology, 2016 - ncbi.nlm.nih.gov
Inhibition and induction of drug-metabolizing enzymes are the most frequent and dangerous
drug-drug interactions. They are an important cause of serious adverse events that have …